About Endobetix
Endobetix is a company based in Misgav (Israel) founded in 2012 by Pierre Sharvit. It operates as a B2B. Endobetix has raised $2.5 million across 1 funding round from investors including The Trendlines Group. Endobetix operates in a competitive market with competitors including Fractyl, GI Dynamics, MetaModix, Allevetix and EndObetes, among others.
- Headquarter Misgav, Israel
- Founders Pierre Sharvit
-
Sectors
Healthcare
-
Phone
*********
-
Website
*********
-
Annual Revenue
-
Net Profit
-
EBITDA
-
Total Equity Funding
$2.5 M (USD)
in 1 rounds
-
Latest Funding Round
$2.5 M (USD), Series A
Oct 31, 2012
- Investors
-
Employee Count
Employee Count
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Funding Insights of Endobetix
Endobetix has successfully raised a total of $2.5M through 1 strategic funding round. The most recent funding activity was a Series A round of $2.5 million completed in October 2012. This substantial capital infusion reflects strong investor confidence in the company's business model, growth potential, and market opportunities. The funding enables strategic expansion, product development, market penetration, and operational scaling to drive long-term value creation and competitive advantage.
- Total Funding Total Funding
- Total Rounds 1
- Last Round Series A — $2.5M
-
First Round
First Round
(31 Oct 2012)
- Investors Count 1
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Oct, 2012 | Amount | Series A - Endobetix | Valuation |
investors |
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Jul, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Jan, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
Investors in Endobetix
Endobetix has secured backing from 1 investor, including venture fund investors. Prominent investors backing the company include The Trendlines Group. This diverse investor base provides strategic capital, industry expertise, and valuable network connections that support the company's growth initiatives, market expansion, and long-term value creation.
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
|
Venture capital fund and startup incubator for healthcare and agricultural companies
|
Founded Year | Domain | Location |
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
|
Single family office of Amitabh Bachchan, founder of Amitabh Bachchan Corporation or AB CORP
|
Founded Year | Domain | Location | |
|
Startup ecosystems are ignited through strategic investments by Signite Partners.
|
Founded Year | Domain | Location | |
|
Venture capital is directed toward companies in multiple sectors.
|
Founded Year | Domain | Location | |
|
Venture capital is invested in cybersecurity, fintech, and AI startups.
|
Founded Year | Domain | Location |
Investments & Acquisitions by Endobetix
| Company Name | Description | Domain | Location | Founded Year | Amount |
|---|---|---|---|---|---|
|
Bionic investment advisor platform
|
2016 | ||||
|
Fine Asian gourmet food is offered by an internet-first restaurant.
|
2016 | ||||
|
Physical e-commerce kiosks are deployed for rural purchases in Indonesia.
|
2014 | ||||
|
Fine Asian gourmet food is offered by an internet-first restaurant.
|
2016 |
Financial Statements - Endobetix
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Jul, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Jan, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
Endobetix Comparisons
Competitors of Endobetix
Endobetix operates in a dynamic and competitive business environment, facing competition from various established players and emerging companies in the market. The competitive landscape includes prominent companies such as Fractyl, GI Dynamics, MetaModix, Allevetix and EndObetes, among others. This competitive environment drives innovation, market differentiation, and strategic positioning as companies strive to capture market share and deliver value to their customers. Understanding the competitive dynamics is crucial for assessing market positioning, identifying growth opportunities, and navigating the challenges inherent in a competitive marketplace.
| Company Name | Domain | Founded year | HQ Location | Description |
|---|---|---|---|---|
| domain | founded_year | HQ Location |
Endoscopic procedures for type-2 diabetes treatment are developed.
|
|
| domain | founded_year | HQ Location |
Endoscopic barriers for diabetes and metabolic disease treatment are developed.
|
|
| domain | founded_year | HQ Location |
Endoscopically introduced bile diversion device
|
|
| domain | founded_year | HQ Location |
Developer of device for controlling hormonal balance
|
|
| domain | founded_year | HQ Location |
Surgical access tool for obesity and diabetes treatment is developed.
|
|
| domain | founded_year | HQ Location |
Non-invasive medical devices for diabetes treatment are developed.
|
| Company Name | Domain | Founded year | HQ Location | Description |
|---|---|---|---|---|
| domain | founded_year | HQ Location |
Multiple services are booked via an app-based platform.
|
|
| domain | founded_year | HQ Location |
On-demand services are booked through an app-based platform.
|
|
| domain | founded_year | HQ Location |
App based platform offering on demand delivery and ride-hailing services
|
|
| domain | founded_year | HQ Location |
Operates an on-demand hyperlocal delivery app for food and groceries.
|
Frequently Asked Questions about Endobetix
When was Endobetix founded?
Endobetix was founded in 2012.
Where is Endobetix located?
Endobetix is headquartered in Misgav, Israel. It is registered at Misgav, Northern District, Israel.
Who is the current CEO of Endobetix?
Chen Porat is the current CEO of Endobetix.
Is Endobetix a funded company?
Endobetix is a funded company, having raised a total of $2.5M across 1 funding round to date. The company's 1st funding round was a Series A of $2.5M, raised on Oct 31, 2012.
What does Endobetix do?
Endobetix endobetix provides an endoscopically introduced device for bile diversion through providing healthcare solutions, developing medical devices, endoscopic solutions, and bile diversion devices. Prioritizing client-centric approaches, it ensures high-quality outcomes, innovation, and sustainable practices in its field. It continues to evolve, meeting industry challenges with strategic approaches.
Who are the top competitors of Endobetix?
Endobetix's top competitors include Fractyl, GI Dynamics and EndObetes.
Who are Endobetix's investors?
Endobetix has 1 investor. Key investors include The Trendlines Group.